We have previously reported that the upregulation of mGluR5 levels in the medial prefrontal cortex (mPFC) plays a pivotal role in both neuropathic pain and accompanying mood disorders, such as depression and anxiety [24]. This evidence concerns the gene GRM5 and depressive disorder.